BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34725784)

  • 21. The prognostic impact of resection margin status varies according to the genetic and morphological evaluation (GAME) score for colorectal liver metastasis.
    Wang HW; Wang LJ; Jin KM; Bao Q; Li J; Wang K; Xing BC
    J Surg Oncol; 2021 Sep; 124(4):619-626. PubMed ID: 34081792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of R1 Resection for Advanced Colorectal Liver Metastases in the Era of Modern Effective Chemotherapy.
    Laurent C; Adam JP; Denost Q; Smith D; Saric J; Chiche L
    World J Surg; 2016 May; 40(5):1191-9. PubMed ID: 26757718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective Study of Perioperative Circulating Tumor DNA Dynamics in Patients Undergoing Hepatectomy for Colorectal Liver Metastases.
    Newhook TE; Overman MJ; Chun YS; Dasari A; Tzeng CD; Cao HST; Raymond V; Parseghian C; Johnson B; Nishioka Y; Kawaguchi Y; Uppal A; Vreeland TJ; Jaimovich A; Arvide EM; Cristo JV; Wei SH; Raghav KP; Morris VK; Lee JE; Kopetz S; Vauthey JN
    Ann Surg; 2023 May; 277(5):813-820. PubMed ID: 35797554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RAS/TP53 Co-mutation is Associated With Worse Survival After Concurrent Resection of Colorectal Liver Metastases and Extrahepatic Disease.
    Lillemoe HA; Passot G; Kawaguchi Y; DeBellis M; Glehen O; Chun YS; Tzeng CD; Aloia TA; Lopez J; Vauthey JN
    Ann Surg; 2022 Aug; 276(2):357-362. PubMed ID: 33351476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases.
    Chun YS; Passot G; Yamashita S; Nusrat M; Katsonis P; Loree JM; Conrad C; Tzeng CD; Xiao L; Aloia TA; Eng C; Kopetz SE; Lichtarge O; Vauthey JN
    Ann Surg; 2019 May; 269(5):917-923. PubMed ID: 28767562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KRAS Mutation Status Predicts Site-Specific Recurrence and Survival After Resection of Colorectal Liver Metastases Irrespective of Location of the Primary Lesion.
    Shindoh J; Nishioka Y; Yoshioka R; Sugawara T; Sakamoto Y; Hasegawa K; Hashimoto M; Kokudo N
    Ann Surg Oncol; 2016 Jun; 23(6):1890-6. PubMed ID: 26786089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic and Therapeutic Implications of Tumor Biology, Including Gene Alterations, in Colorectal Liver Metastases.
    Nishioka Y; Kawaguchi Y; Kothari AN; Odisio BC; Vauthey JN
    J Gastrointest Surg; 2021 Jun; 25(6):1591-1600. PubMed ID: 33742360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of positive surgical margins after resection of colorectal cancer liver metastases: reappraisal in the era of modern chemotherapy.
    Tranchart H; Chirica M; Faron M; Balladur P; Lefevre LB; Svrcek M; de Gramont A; Tiret E; Paye F
    World J Surg; 2013 Nov; 37(11):2647-54. PubMed ID: 23982776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sub-millimeter surgical margin is acceptable in patients with good tumor biology after liver resection for colorectal liver metastases.
    Xu D; Wang HW; Yan XL; Li J; Wang K; Xing BC
    Eur J Surg Oncol; 2019 Sep; 45(9):1551-1558. PubMed ID: 30879931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections.
    Figueras J; Burdio F; Ramos E; Torras J; Llado L; Lopez-Ben S; Codina-Barreras A; Mojal S
    Ann Oncol; 2007 Jul; 18(7):1190-5. PubMed ID: 17434896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic influence of hepatic margin after resection of colorectal liver metastasis: role of modern preoperative chemotherapy.
    Makowiec F; Bronsert P; Klock A; Hopt UT; Neeff HP
    Int J Colorectal Dis; 2018 Jan; 33(1):71-78. PubMed ID: 29098384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One-millimeter cancer-free margin is curative for colorectal liver metastases: a propensity score case-match approach.
    Hamady ZZ; Lodge JP; Welsh FK; Toogood GJ; White A; John T; Rees M
    Ann Surg; 2014 Mar; 259(3):543-8. PubMed ID: 23732261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. APC and PIK3CA Mutational Cooperativity Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colorectal Liver Metastases.
    Yamashita S; Chun YS; Kopetz SE; Maru D; Conrad C; Aloia TA; Vauthey JN
    Ann Surg; 2020 Dec; 272(6):1080-1085. PubMed ID: 28379870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: Impact of RAS mutations.
    Passot G; Chun YS; Kopetz SE; Overman MJ; Conrad C; Aloia TA; Vauthey JN
    Eur J Surg Oncol; 2016 Sep; 42(9):1378-84. PubMed ID: 27358198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of microscopic incomplete resection for colorectal liver metastases on surgical margin recurrence: R1-Contact vs R1 < 1 mm margin width.
    Ausania F; Landi F; Martínez-Pérez A; Sandomenico R; Cuatrecasas M; Pages M; Maurel J; Garcia R; Fuster J; Garcia-Valdecasas JC
    J Hepatobiliary Pancreat Sci; 2022 Apr; 29(4):449-459. PubMed ID: 34995418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of R1 resection for colorectal liver metastases on local recurrence and overall survival in the era of modern chemotherapy: An analysis of 1,428 resection areas.
    Ardito F; Panettieri E; Vellone M; Ferrucci M; Coppola A; Silvestrini N; Arena V; Adducci E; Capelli G; Vecchio FM; Giovannini I; Nuzzo G; Giuliante F
    Surgery; 2019 Apr; 165(4):712-720. PubMed ID: 30482518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colorectal Liver Micrometastases: Association with RAS/TP53 Co-Mutation and Prognosis after Surgery.
    Chun YS; Passot G; Nishioka Y; Katkhuda R; Arvide EM; Benzerdjeb N; Lopez J; Kopetz SE; Maru DM; Vauthey JN
    J Am Coll Surg; 2022 Jul; 235(1):8-16. PubMed ID: 35703957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A New Surveillance Algorithm After Resection of Colorectal Liver Metastases Based on Changes in Recurrence Risk and RAS Mutation Status.
    Kawaguchi Y; Kopetz S; Lillemoe HA; Hwang H; Wang X; Tzeng CD; Chun YS; Aloia TA; Vauthey JN
    J Natl Compr Canc Netw; 2020 Nov; 18(11):1500-1508. PubMed ID: 33152698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is Tumor Detachment from Vascular Structures Equivalent to R0 Resection in Surgery for Colorectal Liver Metastases? An Observational Cohort.
    Viganò L; Procopio F; Cimino MM; Donadon M; Gatti A; Costa G; Del Fabbro D; Torzilli G
    Ann Surg Oncol; 2016 Apr; 23(4):1352-60. PubMed ID: 26714946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resection margin and recurrence-free survival after liver resection of colorectal metastases.
    Muratore A; Ribero D; Zimmitti G; Mellano A; Langella S; Capussotti L
    Ann Surg Oncol; 2010 May; 17(5):1324-9. PubMed ID: 19847565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.